Skip to main content
. 2024 Mar 18;2024:5996218. doi: 10.1155/2024/5996218

Table 2.

The results of subgroup analysis.

Biomarkers Subgroup Number of studies Number of participants
in experiment/control
SMD
(95% CI)
p between subgroups Heterogeneity
I 2 (%) p
HbA1c Region Oceania 2 [21, 25] 81/74 -0.19 (-0.50, 0.12) 0.19 0 0.43
Asia 4 [22-24, 27] 157/162 -0.59 (-1.12, -0.07) 79.82 ﹤0.001
Intervention time <3 m 2 [22, 23] 68/70 -0.88 (-1.79, 0.03) 0.17 82.87 0.02
≥3 m 4 [21, 24, 25, 27] 170/166 -0.23 (-0.44, -0.02) 0 0.61
Sample size <30 3 [23, 25, 27] 62/59 -0.34 (-0.69, 0.02) 0.58 0 0.45
≥30 3 [21, 22, 24] 176/177 -0.56 (-1.28, 0.15) 91.01 ﹤0.001

FBG Region Oceania 2 [21, 25] 85/79 0.05 (-0.25, 0.36) 0.21 0 0.42
Asia 4 [22-24, 27] 157/162 -0.20 (-0.45, 0.06) 21.35 0.35
Intervention time <3 m 2 [22, 23] 68/70 -0.34 (-0.67, -0.01) 0.10 0 0.77
≥3 m 4 [21, 24, 25, 27] 174/171 -0.01 (-0.22, 0.20) 0 0.45
Sample size <30 3 [23, 25, 27] 62/59 -0.22 (-0.60, 0.16) 0.48 12.05 0.26
≥30 3 [21, 22, 24] 180/182 -0.06 (-0.26, 0.15) 0 0.35

HOMA-IR Region Oceania 1 [21] 70/68 -0.13 (-0.46, 0.21) 0.31
Asia 4 [22-24, 27] 157/162 -0.33 (-0.55, -0.11) 0 0.97
Intervention time <3 m 2 [22, 23] 68/70 -0.40 (-0.73, -0.06) 0.38 0 0.99
≥3 m 3 [21, 24, 27] 159/160 -0.22 (-0.43, 0.00) 0 0.78
Sample size <30 2 [23, 27] 47/48 -0.31 (-0.71, 0.09) 0.81 0 0.71
≥30 3 [21, 22, 24] 180/182 -0.26 (-0.46, -0.05) 0 0.58

Insulin Region Oceania 2 [21, 25] 85/79 -0.03 (-0.35, 0.30) 0.63 6.18 0.30
Asia 4 [22-24, 27] 157/162 -0.13 (-0.42, 0.15) 36.26 0.22
Intervention time <3 m 2 [22, 23] 68/70 -0.02 (-0.58, 0.54) 0.66 58.71 0.12
≥3 m 4 [21, 24, 25, 27] 174/171 -0.15 (-0.36, 0.06) 0 0.52
Sample size <30 3 [23, 25, 27] 62/59 -0.14 (-0.49, 0.21) 0.77 0 0.33
≥30 3 [21, 22, 24] 180/182 -0.07 (-0.35, 0.21) 44.39 0.16

TC Region Oceania 2 [21, 25] 84/79 0.04 (-0.27, 0.34) 0.28 0 0.58
Asia 2 [22, 26] 76/77 -1.66 (-4.74, 1.43) 98.34 ﹤0.001
Intervention time <3 m 2 [22, 26] 76/77 -1.66 (-4.74, 1.43) 0.28 98.34 ﹤0.001
≥3 m 2 [21, 25] 84/79 0.04 (-0.27, 0.34) 0 0.58
Sample size <30 2 [25, 26] 43/38 0.02 (-0.41, 0.45) 0.32 0 0.50
≥30 2 [21, 22] 117/118 -1.61 (-4.78, 1.56) 98.83 ﹤0.001

TG Region Oceania 2 [21, 25] 84/79 0.10 (-0.21, 0.40) 0.42 0 0.41
Asia 2 [22, 26] 76/77 -0.94 (-3.42, 1.54) 97.87 ﹤0.001
Intervention time <3 m 2 [22, 26] 76/77 -0.94 (-3.42, 1.54) 0.42 97.87 ﹤0.001
≥3 m 2 [21, 25] 84/79 0.10 (-0.21, 0.40) 0 0.41
Sample size <30 2 [25, 26] 43/38 0.14 (-0.35, 0.63) 0.34 19.12 0.27
≥30 2 [21, 22] 117/118 -1.02 (-3.33, 1.29) 98.31 ﹤0.001

HDL Region Oceania 2 [21, 25] 84/79 0.34 (0.03, 0.64) 0.00 0 0.93
Asia 2 [22, 26] 76/77 1.31 (0.96, 1.65) 0 0.34
Intervention time <3 m 2 [22, 26] 76/77 1.31 (0.96, 1.65) 0.00 0 0.34
≥3 m 22 [21, 25] 84/79 0.34 (0.03, 0.64) 0 0.93
Sample size <30 2 [25, 26] 43/38 0.78 (0.07, 1.48) 0.88 55.88 0.13
≥30 2 [21, 22] 117/118 0.88 (-0.21, 1.96) 93.48 ﹤0.001

LDL Region Oceania 2 [21, 25] 84/78 0.03 (-0.28, 0.33) 0.14 0 0.69
Asia 2 [22, 26] 76/77 -1.98 (-4.60, 0.64) 97.61 ﹤0.001
Intervention time <3 m 2 [22, 26] 76/77 -1.98 (-4.60, 0.64) 0.14 97.61 ﹤0.001
≥3 m 2 [21, 25] 84/78 0.03 (-0.28, 0.33) 0 0.69
Sample size <30 2 [25, 26] 43/38 -0.29 (-1.08, 0.51) 0.42 66.77 0.08
≥30 2 [21, 22] 117/117 -1.65 (-4.91, 1.61) 98.86 ﹤0.001

BMI Region Oceania 2 [21, 25] 85/79 0.22 (-0.08, 0.53) 0.80 0 1.00
Asia 3 [22, 24, 27] 137/142 0.14 (-0.48, 0.75) 84.56 ﹤0.001
Intervention time <3 m 1 [22] 48/50 0.74 (0.34, 1.15) 0.00
≥3 m 4 [21, 24, 25, 27] 174/171 0.03 (-0.21, 0.27) 17.57 0.33
Sample size <30 2 [25, 27] 42/39 -0.11 (-0.62, 0.39) 0.24 22.95 0.25
≥30 3 [21, 22, 24] 180/182 0.29 (-0.16, 0.74) 78.61 0.01

Intervention time: month (m).